Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,760,907
+$152,733 QoQ
Shares Held
10,871
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#2,063
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TFR Capital, LLC. holds $14,292,120 across 7 Drug Manufacturers - General names. JNJ ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,709 | $5,648,116 | |
| 2 | ABBV |
AbbVie Inc.
|
16,506 | $4,153,569 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,871 | $2,760,907 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,757 | $868,274 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,423 | $306,121 | |
| 6 | AMGN |
Amgen Inc
|
820 | $296,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,481 | $258,195 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,760,907 | 10,871 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,608,174 | 10,670 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $692,040 | 3,344 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $625,421 | 3,373 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $511,712 | 3,350 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $733,510 | 4,423 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $312,668 | 2,162 | Shares | Sole | 2025-03-06 | |
| No filing history on record for this holder in this stock. | ||||||